首页|基于真实世界数据的肺癌根治术中不同可吸收止血纱使用方式评价

基于真实世界数据的肺癌根治术中不同可吸收止血纱使用方式评价

扫码查看
目的 评估不同的可吸收止血纱使用方式在腔镜下肺癌根治术中的有效性、安全性和经济性.为可吸收止血材料的遴选、临床选择和合理使用提供参考.方法 回顾性搜集2019年7月至2020年1月和2020年7月至2020年12月在某三甲医院行腔镜下肺癌根治术的住院患者资料,根据可吸收止血纱使用方式的不同将患者分为两组:联合使用组(再生氧化纤维素止血纱和胶原蛋白海绵)和单种使用组(再生氧化纤维素止血纱),比较两组的有效性、安全性、经济性结局指标.结果 主分析共纳入患者904例,其中联合使用组466例,单种使用组438例.相较于联合使用组,单种使用组的住院时间更长,但患者止血药使用率下降,止血材料费用均数降低,总住院费用中位数降低,差异均具有统计学意义(P<0.05);未发现两组在术中出血量、大量血液损失率、围术期输血率、二次手术率、术后48 h引流量、鲜血性引流液率、术后检验指标方面差异有统计学意义.结论 在腔镜下肺癌根治术中仅使用可吸收止血纱与联合使用在有效性和安全性方面无较大差异,但单独使用降低了止血材料费用和住院总费用.在保证治疗效果的前提下,在腔镜下肺癌根治术中只使用可吸收止血纱可能是更具经济性的选择.
Comparison of different ORC uses in VATS for lung cancer resection based on real-world data
Objective To evaluate the safety,efficacy,and cost-effectiveness of different uses of oxidized regenerated cellulose(ORC)in video-assisted thoracoscopic surgery(VATS)for lung cancer resection to provide a reference for the selection,clinical use,and rational utilization of absorbable hemostatic materials.Methods A retrospective analysis of relevant data from inpatients who underwent VATS for lung cancer resection at a tertiary hospital from July 2019 to January 2020 and from July 2020 to December 2020 was conducted.Patients were divided into two groups based on the use of ORC:1)combined use group(ORC and collagen sponge)and 2)sole-use group(ORC).Safety,efficacy,and economic outcome indicators were compared between the two groups.Results The main analysis included a total of 904 patients,with 466 in the combined use group and 438 in the sole-use group.Compared to the combined use group,the sole-use group had a significantly longer hospital stay,used fewer hemostatic drugs,had a lower average cost of hemostatic materials,and a lower median total hospitalization cost(P<0.05).No statistically significant difference was found between the two groups in terms of intraoperative blood loss volume,massive blood loss rate,perioperative transfusion rate,reoperation rate,postoperative 48-hour drainage volume,bloody drainage fluid rate,or postoperative laboratory test indicators.Conclusion There was no significant difference in the safety or efficacy of VATS for lung cancer resection between the sole use of ORC and the combined use of ORC,but the sole use of ORC was associated with a lower cost of hemostatic materials and a lower total hospitalization cost.The sole use of hemostatic gauze in VATS for lung cancer resection may be a more cost-effective choice.

Real-world studyPropensity scoreAbsorbable hemostatic gauzeVideo-assisted thoracoscopic surgerySafetyEfficacy

潘燕君、孙静、潘瑾、吴韬、胡坚、冯靖祎

展开 >

浙江大学医学院附属第一医院医学工程与物资部(杭州 310003)

浙江省医疗器械临床评价技术研究重点实验室(杭州 310003)

浙江大学医学院附属第一医院普胸外科(杭州 310003)

真实世界研究 倾向性得分 可吸收止血纱 腔镜下肺癌根治术 安全性 有效性

浙江省自然科学基金浙江省自然科学基金浙江省医药卫生科研面上项目国家卫生健康委医院管理研究所项目

LQ21H180009LQ20C1000012021KY6852021-12

2024

中国循证医学杂志
四川大学

中国循证医学杂志

CSTPCD北大核心
影响因子:1.761
ISSN:1672-2531
年,卷(期):2024.24(5)
  • 28